HA
CME icon

Harfst & Associates’s CME Group CME Stock Holding History

Harfst & Associates’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,964
Closed -$401K – 140
2021
Q1 		$401K Sell
1,964
-4,346
-69% -$856K 0.12% 116
2020
Q4 		$1.15M Buy
6,310
+1,747
+38% +$297K 0.42% 43
2020
Q3 		$763K Buy
4,563
+882
+24% +$149K 0.32% 50
2020
Q2 		$598K Buy
3,681
+2,431
+194% +$436K 0.26% 57
2020
Q1 		$216K Buy
1,250
+54
+5% +$10.7K 0.11% 91
2019
Q4 		$240K Sell
1,196
-17
-1% -$3.49K 0.09% 91
2019
Q3 		$256K Buy
1,213
+62
+5% +$13K 0.11% 85
2019
Q2 		$223K Buy
+1,151
New +$212K 0.09% 90
2019
Q1 		– Sell
-1,105
Closed -$207K – 96
2018
Q4 		$207K Buy
+1,105
New +$204K 0.1% 85

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Harfst & Associates's CME Position: Q2 2021 in Review

Harfst & Associates sold out of CME Group (CME) in Q2 2021, closing a stake of 1,964 shares — an estimated $401K sold.

Harfst & Associates first reported a position in CME in Q4 2018 and held it in 9 quarters. The position peaked at $1.15M in Q4 2020. 1,087 funds tracked by Wall St. Rank hold CME as of Q2 2021.

  • Harfst & Associates reported no remaining CME Group position as of Q2 2021 after selling out during the quarter.
  • Harfst & Associates sold 1,964 CME Group shares in Q2 2021, an estimated $401K.
  • Harfst & Associates first reported a position in CME Group in Q4 2018 and held it in 9 quarters.
  • Harfst & Associates's CME Group position peaked at $1.15M in Q4 2020.
  • 1,087 funds tracked by Wall St. Rank held CME Group as of Q2 2021.

Based on Harfst & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.